Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 5
2013 8
2014 7
2015 5
2016 2
2017 4
2018 6
2019 4
2020 2
2021 9
2022 21
2023 27
2024 14
2025 17
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: irving sa. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. Lancet. 2024. PMID: 39426837 Free PMC article.
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
Frutos AM, Cleary S, Reeves EL, Ahmad HM, Price AM, Self WH, Zhu Y, Safdar B, Peltan ID, Gibbs KW, Exline MC, Lauring AS, Ball SW, DeSilva M, Tartof SY, Dascomb K, Irving SA, Klein NP, Dixon BE, Ong TC, Vaughn IA, House SL, Faryar KA, Nowalk MP, Gaglani M, Wernli KJ, Murugan V, Williams OL, Selvarangan R, Weinberg GA, Staat MA, Halasa NB, Sahni LC, Michaels MG, Englund JA, Kirby MK, Surie D, Dawood FS, Clopper BR, Moline HL, Link-Gelles R, Payne AB, Harker E, Wielgosz K, Weber ZA, Yang DH, Lewis NM, DeCuir J, Olson SM, Chung JR, Flannery B, Grohskopf LA, Reed C, Garg S, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Frutos AM, et al. Among authors: irving sa. MMWR Morb Mortal Wkly Rep. 2025 Feb 27;74(6):83-90. doi: 10.15585/mmwr.mm7406a2. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40014791 Free PMC article.
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.
Wiegand RE, Chickery S, Yang DH, Ball SW, DeSilva MB, Dascomb K, Irving SA, Natarajan K, Klein NP, Grannis SJ, Ong TC, Rowley EAK, Yates A, Zhuang Y, Wilson S, McEvoy CE, Essien IJ, Akinsete OO, Naleway AL, Koppolu P, Zerbo O, Hansen JR, Jacobson KB, Block L, Dixon BE, Duszynski T, Rogerson C, Barron MA, Chavez C, Mak J, Ciesla AA, Godfrey M, Kautz A, Najdowski M, Link-Gelles R, DeCuir J, Payne AB. Wiegand RE, et al. Among authors: irving sa. JAMA Netw Open. 2026 Jun 1;9(6):e2625152. doi: 10.1001/jamanetworkopen.2026.25152. JAMA Netw Open. 2026. PMID: 42334917 Free PMC article.
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults.
Link-Gelles R, Rowley EAK, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Dascomb K, Naleway AL, Koppolu P, Zerbo O, Fireman B, Hansen J, Timbol J, Block L, Dixon BE, Duszynski TJ, Allen KS, Mayer D, Chavez C, Barron M, Reese SE, Chickery S, Davis JM, Ciesla AA, Mak J, Najdowski M, Akinsete OO, McEvoy CE, Essien IJ, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Natarajan K, Tenforde MW, DeCuir J, Payne AB. Link-Gelles R, et al. Among authors: irving sa. JAMA Netw Open. 2025 Jun 2;8(6):e2517402. doi: 10.1001/jamanetworkopen.2025.17402. JAMA Netw Open. 2025. PMID: 40560584 Free PMC article.
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.
Irving SA, Rowley EAK, Chickery S, Natarajan K, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Dascomb K, Naleway AL, Stockwell MS, Stephens AB, Zerbo O, Hansen J, Block L, Jacobson KB, Dixon BE, Rogerson C, Duszynski T, Barron MA, Mayer D, Chavez C, Weber ZA, Reese SE, Essien I, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Koppolu P, Mak J, Kautz A, DeCuir J, Wiegand RE, Payne AB, Link-Gelles R. Irving SA, et al. MMWR Morb Mortal Wkly Rep. 2025 Dec 11;74(40):607-614. doi: 10.15585/mmwr.mm7440a1. MMWR Morb Mortal Wkly Rep. 2025. PMID: 41379943 Free PMC article.
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis.
Payne AB, Battan-Wraith S, Rowley EAK, Stockwell MS, Tartof SY, Dascomb K, Irving SA, Dixon B, Ball SW, Tenforde MW, Vazquez-Benitez G, Stephens AB, Han J, Natarajan K, Salas SB, Bezi C, Sy LS, Lewin B, Sheffield T, Arndorfer J, Bride D, Van Otterloo J, Naleway AL, Koppolu PD, Grannis S, Fadel W, Rogerson C, Duszynski T, Reese SE, Mitchell PK, Chickery S, Moline HL, Najdowski M, Ciesla AA, Reeves EL, DeSilva M, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: irving sa. Lancet Reg Health Am. 2025 Aug 6;49:101196. doi: 10.1016/j.lana.2025.101196. eCollection 2025 Sep. Lancet Reg Health Am. 2025. PMID: 41040536 Free PMC article.
Postmenopausal bleeding after COVID-19 vaccination.
Kauffman TL, Irving SA, Brooks N, Vesco KK, Slaughter M, Smith N, Tepper NK, Olson CK, Weintraub ES, Naleway AL; Vaccine Safety Datalink Menstrual Irregularities Workgroup. Kauffman TL, et al. Among authors: irving sa. Am J Obstet Gynecol. 2024 Jan;230(1):71.e1-71.e14. doi: 10.1016/j.ajog.2023.09.007. Epub 2023 Sep 17. Am J Obstet Gynecol. 2024. PMID: 37726057 Free PMC article.
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators; CDC Influenza Vaccine Effectiveness Collaborators. Maloney P, et al. Among authors: irving sa. MMWR Morb Mortal Wkly Rep. 2026 Mar 12;75(9):116-123. doi: 10.15585/mmwr.mm7509a2. MMWR Morb Mortal Wkly Rep. 2026. PMID: 41818161 Free PMC article.
Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza Season.
Azziz-Baumgartner E, Budd A, Lee JS, Iuliano AD, Ellington SR, Levine MZ, Zheng XY, Gubareva L, Adams K, DeCuir J, Bozio CH, Reed C, Kirby MK, Rambo-Martin B, Jones JM, Biggerstaff M, Garg S, Davis CT, Shimabukuro TT, Burns E, Kondor R, Olsen SJ, Dugan VG; VISION Coauthors; Irving SA, Naleway AL, Dascomb K, Sheffield T, DeSilva MB, Tartof SY, Sy LS, Klein NP, Zerbo O, Grannis SJ, Dixon BE, Stockwell MS, Stephens AB, Ong TC, Barron MA, Ball SW, Weber ZA, Reeves EL, Ray CS. Azziz-Baumgartner E, et al. Among authors: irving sa. JAMA Netw Open. 2026 Jun 1;9(6):e2618581. doi: 10.1001/jamanetworkopen.2026.18581. JAMA Netw Open. 2026. PMID: 42307948 Free PMC article.
134 results